Clinical Trials Browser

Completed × Interventional × Basiliximab × Clear all

NCT01526096 2025-11-05

Stem Cell Transplantation for Patients With Multiple Myeloma

Phase 1 Completed

Neoplasms, Plasma Cell

NCT01476839 2025-03-20

Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma

Phase 1 Completed

Hodgkin Disease

NCT02366728 2023-06-08

ELEVATE

Phase 2 Completed

64 enrolled 17 charts

Glioblastoma

NCT00626483 2021-03-09

REGULATe

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00975975 2016-02-26

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Phase 2 Completed

17 enrolled 9 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hemoglobinuria, Paroxysmal, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis